The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The construction of a lymphoma cell-based, DC-targeted vaccine, and its application in lymphoma prevention and cure
Authors
Keywords
Non-hodgkin lymphoma, DCs targeting, Man-EG7/CH@CpG vaccine, Combinational therapy
Journal
Bioactive Materials
Volume 6, Issue 3, Pages 697-711
Publisher
Elsevier BV
Online
2020-09-22
DOI
10.1016/j.bioactmat.2020.09.002
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles
- (2020) Ziling Zeng et al. ADVANCED FUNCTIONAL MATERIALS
- Electromagnetic nanomedicines for combinational cancer immunotherapy
- (2020) Kanyi Pu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
- (2019) A. Capasso et al. Journal for ImmunoTherapy of Cancer
- Role of Targeted Therapy and Immune Checkpoint Blockers in Advanced Non‐Small Cell Lung Cancer: A Review
- (2019) Nagla Abdel Karim et al. ONCOLOGIST
- Cy5.5-MSA-G250 nanoparticles (CMGNPs) induce M1 polarity of RAW264. 7 macrophage cells via TLR4-dependent manner
- (2019) Zhuoxuan Lu et al. CHINESE CHEMICAL LETTERS
- Anti-Tumor Activity of Mannose-CpG-Oligodeoxynucleotides-Conjugated and Hepatoma Lysate-Loaded Nanoliposomes for Targeting Dendritic Cells In Vivo
- (2019) Xiaomei Yang et al. Journal of Biomedical Nanotechnology
- Material design for lymph node drug delivery
- (2019) Alex Schudel et al. Nature Reviews Materials
- Organic Semiconducting Pro-nanostimulants for Near-Infrared Photoactivatable Cancer Immunotherapy
- (2019) Jingchao Li et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nano-Porous Silica Aerogels as Promising Biomaterials for Oral Drug Delivery of Paclitaxel
- (2019) Xiaoxiao Wang et al. Journal of Biomedical Nanotechnology
- Bioinspired Drug Delivery Carrier for Enhanced Tumor-Targeting in Melanoma Mice Model
- (2019) Xu Wang et al. Journal of Biomedical Nanotechnology
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017
- (2019) et al. JAMA Oncology
- Study on bioactive molecules involved in extracellular biosynthesis of silver nanoparticles by Penicillium aculeatum Su1
- (2019) Liang Ma et al. Materials Express
- Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial
- (2019) Viola Poeschel et al. LANCET
- Tumor-Derived TGFβ Alters the Ability of Plasmacytoid Dendritic Cells to Respond to Innate Immune Signaling
- (2018) Mariana Terra et al. CANCER RESEARCH
- Recent progress of fully synthetic carbohydrate-based vaccine using TLR agonist as build-in adjuvant
- (2018) Zhifang Zhou et al. CHINESE CHEMICAL LETTERS
- A photocleavable low molecular weight hydrogel for light-triggered drug delivery
- (2018) Qihong Liu et al. CHINESE CHEMICAL LETTERS
- Enhanced In Vitro and In Vivo Anticancer Properties by Using a Nanocarrier for Co-Delivery of Antitumor Polypeptide and Curcumin
- (2018) Mengjiao Qi et al. Journal of Biomedical Nanotechnology
- Chemical Modification of Chitosan for Efficient Vaccine Delivery
- (2018) Lei Xing et al. MOLECULES
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- Poly(N-vinyl caprolactam) thermoresponsive polymer in novel drug delivery systems: A review
- (2018) Marwah N. Mohammed et al. Materials Express
- Biomaterial-assisted targeted modulation of immune cells in cancer treatment
- (2018) Hua Wang et al. NATURE MATERIALS
- A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
- (2018) Miguel F. Sanmamed et al. CELL
- Surface engineering tumor cells with adjuvant-loaded particles for use as cancer vaccines
- (2017) Kawther K. Ahmed et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib
- (2017) Samuel J. Taylor et al. Science Translational Medicine
- Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression
- (2017) Jianqin Lu et al. Nature Communications
- The Basis of Oncoimmunology
- (2016) A. Karolina Palucka et al. CELL
- Dendritic cell-based immunotherapy
- (2016) Rachel L Sabado et al. CELL RESEARCH
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy
- (2016) Seung-Hwan Park et al. Theranostics
- Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity
- (2015) Kirsten Lauber et al. CANCER LETTERS
- Nuclear FAK Controls Chemokine Transcription, Tregs, and Evasion of Anti-tumor Immunity
- (2015) Alan Serrels et al. CELL
- A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas
- (2015) Pierre Feugier Future Oncology
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variation in cancer risk among tissues can be explained by the number of stem cell divisions
- (2015) C. Tomasetti et al. SCIENCE
- The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies
- (2015) Leisha A. Emens et al. Cancer Immunology Research
- Ovarian cancer chemokines may not be a significant barrier during whole tumor antigen dendritic-cell vaccine and adoptive T-cell immunotherapy
- (2015) Emese Zsiros et al. OncoImmunology
- Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
- (2014) S. Loi et al. ANNALS OF ONCOLOGY
- COSMIC: exploring the world's knowledge of somatic mutations in human cancer
- (2014) Simon A. Forbes et al. NUCLEIC ACIDS RESEARCH
- Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
- (2014) Julia Scheiermann et al. VACCINE
- Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
- (2014) Aparna Areti et al. Redox Biology
- Nanoparticles-based multi-adjuvant whole cell tumor vaccine for cancer immunotherapy
- (2013) Shi-Ying Liu et al. BIOMATERIALS
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
- (2013) Zhenghong Xu et al. JOURNAL OF CONTROLLED RELEASE
- Sindbis Viral Vectors Transiently Deliver Tumor-associated Antigens to Lymph Nodes and Elicit Diversified Antitumor CD8+ T-cell Immunity
- (2013) Tomer Granot et al. MOLECULAR THERAPY
- Allogeneic tumor cell vaccines
- (2013) Sanjay Srivatsan et al. Human Vaccines & Immunotherapeutics
- Chitosan-based drug delivery systems
- (2012) Andreas Bernkop-Schnürch et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Vaccine Injection Site Matters: Qualitative and Quantitative Defects in CD8 T Cells Primed as a Function of Proximity to the Tumor in a Murine Glioma Model
- (2012) J. R. Ohlfest et al. JOURNAL OF IMMUNOLOGY
- Identification of the molecular basis of doxorubicin-induced cardiotoxicity
- (2012) Sui Zhang et al. NATURE MEDICINE
- The Tipping Point for Combination Therapy: Cancer Vaccines With Radiation, Chemotherapy, or Targeted Small Molecule Inhibitors
- (2012) James W. Hodge et al. SEMINARS IN ONCOLOGY
- Cross-priming for antitumor CTL induced by soluble Ag + polyI:C depends on the TICAM-1 pathway in mouse CD11c+/CD8α+dendritic cells
- (2012) Masahiro Azuma et al. OncoImmunology
- Pharmacokinetic Evaluation of a DSPE-PEG2000 Micellar Formulation of Ridaforolimus in Rat
- (2012) Connie Remsberg et al. Pharmaceutics
- Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer
- (2011) Neil Senzer et al. MOLECULAR THERAPY
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Therapeutic cancer vaccines: are we there yet?
- (2010) Christopher A. Klebanoff et al. IMMUNOLOGICAL REVIEWS
- CD169+ macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes
- (2010) Patricia Barral et al. NATURE IMMUNOLOGY
- TLR-based immune adjuvants
- (2010) Folkert Steinhagen et al. VACCINE
- Antigens for cancer immunotherapy
- (2008) Michelle A. Neller et al. SEMINARS IN IMMUNOLOGY
- Whole tumor cell vaccine with irradiated S180 cells as adjuvant
- (2008) Jinhua Li et al. VACCINE
- Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells
- (2007) Khalil Karimi et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started